Genpact Reports Full Year and Fourth Quarter 2024 Results
Genpact (NYSE: G) reported strong financial results for 2024, with net revenues reaching $4.77 billion, up 6.5% year-over-year. Data-Tech-AI revenues grew 6.9% to $2.23 billion, while Digital Operations revenues increased 6.1% to $2.53 billion.
The company achieved record new bookings of $5.7 billion, up 15% from 2023. While diluted EPS decreased 16% to $2.85, adjusted diluted EPS rose 10% to $3.28. Cash generated from operations improved 25% to $615 million.
Looking ahead to 2025, Genpact projects net revenues between $5.029-5.125 billion, representing 5.5-7.5% growth. The company increased its quarterly dividend by 11% to $0.17 per share and approved a $500 million increase to its share repurchase authorization.
Genpact (NYSE: G) ha riportato risultati finanziari solidi per il 2024, con ricavi netti che hanno raggiunto 4,77 miliardi di dollari, in crescita del 6,5% rispetto all'anno precedente. I ricavi di Data-Tech-AI sono aumentati del 6,9% fino a 2,23 miliardi di dollari, mentre i ricavi delle Operazioni Digitali sono aumentati del 6,1% a 2,53 miliardi di dollari.
L'azienda ha raggiunto un record di nuove prenotazioni per 5,7 miliardi di dollari, con un incremento del 15% rispetto al 2023. Sebbene l'utile per azione diluito sia diminuito del 16% a 2,85 dollari, l'utile per azione diluito rettificato è aumentato del 10% a 3,28 dollari. Il cash generato dalle operazioni è migliorato del 25% arrivando a 615 milioni di dollari.
Guardando al 2025, Genpact prevede ricavi netti compresi tra 5,029 e 5,125 miliardi di dollari, con una crescita prevista del 5,5-7,5%. L'azienda ha aumentato il dividendo trimestrale dell'11% a 0,17 dollari per azione e ha approvato un aumento di 500 milioni di dollari nell'autorizzazione al riacquisto di azioni.
Genpact (NYSE: G) reportó resultados financieros sólidos para 2024, con ingresos netos que alcanzaron 4.77 mil millones de dólares, un aumento del 6.5% interanual. Los ingresos de Data-Tech-AI crecieron un 6.9% hasta los 2.23 mil millones de dólares, mientras que los ingresos de Operaciones Digitales aumentaron un 6.1% a 2.53 mil millones de dólares.
La empresa lograron nuevos pedidos récord de 5.7 mil millones de dólares, un 15% más que en 2023. Aunque el EPS diluido disminuyó un 16% a 2.85 dólares, el EPS diluido ajustado aumentó un 10% a 3.28 dólares. El flujo de efectivo generado por las operaciones mejoró un 25% a 615 millones de dólares.
Mirando hacia 2025, Genpact proyecta ingresos netos entre 5.029 y 5.125 mil millones de dólares, representando un crecimiento del 5.5-7.5%. La empresa aumentó su dividendo trimestral en un 11% a 0.17 dólares por acción y aprobó un aumento de 500 millones de dólares en su autorización de recompra de acciones.
Genpact (NYSE: G)는 2024년 강력한 재무 결과를 보고했으며, 순수익이 47억7000만 달러에 도달하여 전년 대비 6.5% 증가했습니다. Data-Tech-AI의 수익은 6.9% 증가하여 22억3000만 달러에 달했고, 디지털 운영의 수익은 6.1% 증가하여 25억3000만 달러에 달했습니다.
회사는 57억 달러의 신규 계약 기록을 달성했으며, 이는 2023년 대비 15% 증가한 수치입니다. 희석 주당순이익(EPS)은 16% 감소하여 2.85달러였으나, 조정 희석 EPS는 10% 증가하여 3.28달러에 달했습니다. 영업에서 발생한 현금은 25% 증가하여 6억1500만 달러를 기록했습니다.
2025년을 바라보며, Genpact는 순수익이 50억2900만 달러에서 51억2500만 달러 사이에 이를 것으로 예상하며, 이는 5.5-7.5%의 성장을 나타냅니다. 또한 분기 배당금을 11% 증가시켜 주당 0.17달러로 설정했으며, 자사주 매입 승인 금액을 5억 달러 증가시켰습니다.
Genpact (NYSE: G) a annoncé de solides résultats financiers pour 2024, avec des revenus nets atteignant 4,77 milliards de dollars, en hausse de 6,5 % par rapport à l'année précédente. Les revenus de Data-Tech-AI ont augmenté de 6,9 % pour atteindre 2,23 milliards de dollars, tandis que les revenus des Opérations Digitales ont progressé de 6,1 % pour s'établir à 2,53 milliards de dollars.
La société a atteint un nouveau record de nouvelles commandes de 5,7 milliards de dollars, soit une augmentation de 15 % par rapport à 2023. Bien que le BPA dilué ait diminué de 16 % pour atteindre 2,85 dollars, le BPA dilué ajusté a augmenté de 10 % à 3,28 dollars. La trésorerie générée par les opérations a augmenté de 25 % pour atteindre 615 millions de dollars.
En prévision de 2025, Genpact prévoit des revenus nets compris entre 5,029 et 5,125 milliards de dollars, représentant une croissance de 5,5 à 7,5 %. L'entreprise a augmenté son dividende trimestriel de 11 % pour atteindre 0,17 dollar par action et a approuvé une augmentation de 500 millions de dollars de son autorisation de rachat d'actions.
Genpact (NYSE: G) hat im Jahr 2024 starke Finanzergebnisse gemeldet, mit Nettoumsatz von 4,77 Milliarden US-Dollar, was einem Anstieg von 6,5 % im Jahresvergleich entspricht. Der Umsatz von Data-Tech-AI wuchs um 6,9 % auf 2,23 Milliarden US-Dollar, während die Umsätze im Bereich Digitale Operationen um 6,1 % auf 2,53 Milliarden US-Dollar stiegen.
Das Unternehmen erzielte Rekordneubestellungen von 5,7 Milliarden US-Dollar, was einem Anstieg von 15 % im Vergleich zu 2023 entspricht. Während der verwässerte Gewinn je Aktie um 16 % auf 2,85 US-Dollar fiel, stieg der angepasste verwässerte Gewinn je Aktie um 10 % auf 3,28 US-Dollar. Der aus dem operativen Geschäft generierte Cash Flow verbesserte sich um 25 % auf 615 Millionen US-Dollar.
Für 2025 prognostiziert Genpact Nettoumsätze zwischen 5,029 und 5,125 Milliarden US-Dollar, was einem Wachstum von 5,5 bis 7,5 % entspricht. Das Unternehmen erhöhte die vierteljährliche Dividende um 11 % auf 0,17 US-Dollar pro Aktie und genehmigte eine Erhöhung von 500 Millionen US-Dollar für sein Aktienrückkaufprogramm.
- Record new bookings of $5.7 billion, up 15% YoY
- Cash generated from operations increased 25% to $615 million
- Adjusted diluted EPS grew 10% to $3.28
- 11% dividend increase and $500M additional share repurchase authorization
- Q4 revenue growth accelerated to 8.9%
- Net income declined 19% YoY to $514 million
- Diluted EPS decreased 16% to $2.85
- Q4 net income down 51% YoY
- Q4 diluted EPS decreased 50% YoY
Insights
Genpact's 2024 results reveal a compelling growth story, particularly in its strategic segments. The Data-Tech-AI division, contributing
The company's profitability metrics show mixed signals: while gross margin improved to
The
Looking ahead, Genpact's 2025 guidance of
2024 Net Revenues of
2024 Data-Tech-AI Net Revenues of
2024 Digital Operations Net Revenues of
2024 Diluted EPS of
Increases Quarterly Dividend by
"We delivered another strong quarter to close out what has been an outstanding year for Genpact. Q4 revenue grew
Key Financial Highlights – Full Year 2024
- Net revenues were
, up$4.77 billion 6.5% year-over-year on an as reported basis, and6.7% on a constant currency basis.1,2 - Data-Tech-AI net revenues were
, up$2.23 billion 6.9% year-over-year, both on an as reported and constant currency basis,1,2,4 representing47% of total revenue. - Digital Operations net revenues were
, up$2.53 billion 6.1% year-over-year on an as reported basis, and6.5% on a constant currency basis,1,4 representing53% of total revenue. - Gross profit was
, up$1.69 billion 8% year-over-year, with a corresponding margin of35.5% . - Net income was
, down$514 million 19% year-over-year, with a corresponding margin of10.8% .6 - Income from operations was
, up$702 million 11% year-over-year, with a corresponding margin of14.7% . - Adjusted income from operations was
, up$814 million 7% year-over-year, with a corresponding margin of17.1% .6,7 - Diluted earnings per share was
, down$2.85 16% year-over-year.6 - Adjusted diluted earnings per share was
, up$3.28 10% year-over-year.5,6 - New bookings were approximately
, up$5.7 billion 15% year-over-year.8 - Cash generated from operations was
, up$615 million 25% year-over-year. - Genpact repurchased approximately 7 million of its common shares during the year for total consideration of approximately
at an average price per share of$253 million .$38.31
Key Financial Highlights – Fourth Quarter 2024
- Net revenues were
, up$1.25 billion 8.9% year-over-year on an as reported basis and8.7% on a constant currency basis.1 - Data-Tech-AI net revenues were
, up$595 million 11.9% year-over-year on an as reported basis, and11.7% on a constant currency basis,1,4 representing48% of total revenue. - Digital Operations net revenues were
, up$654 million 6.4% year-over-year on an as reported and6.1% on a constant currency basis,1,4 representing52% of total revenue. - Gross profit was
, up$446 million 9% year-over-year, with a corresponding margin of35.7% . - Net income was
, down$142 million 51% year-over-year, with a corresponding margin of11.4% .6 - Income from operations was
, up$190 million 17% year-over-year, with a corresponding margin of15.2% . - Adjusted income from operations was
, up$221 million 9% year-over-year, with a corresponding margin of17.7% .6,7 - Diluted earnings per share was
, down$0.79 50% year-over-year.6 - Adjusted diluted earnings per share was
, up$0.91 11% year-over-year.5,6 - Cash generated from operations was
, compared to$203 million in the fourth quarter of 2023.$192 million - Genpact repurchased approximately 2 million of its common shares during the quarter for total consideration of approximately
at an average price per share of$85 million .$45.41
Capital Allocation
- Genpact's Board of Directors declared a quarterly cash dividend for the first quarter of 2025 of
per common share, an$0.17 11% increase, payable on March 26, 2025 to shareholders of record as of the close of business on March 11, 2025, and approved a increase to the Company's existing share repurchase authorization. The newly approved quarterly dividend represents a planned annual dividend of$500 million per common share, increased from$0.68 per common share in 2024.$0.61
Outlook
Genpact's outlook for the full year 2025 is as follows:
- Net revenues in the range of
to$5.02 9 billion , representing year-over-year growth of approximately$5.12 5 billion5.5% to7.5% as reported, or6.2% to8.2% on a constant currency basis.1- Data-Tech-AI net revenues growth of approximately
6.2% year-over-year and Digital Operations net revenues growth of approximately6.8% year-over-year as reported at the midpoint of the range. - Data-Tech-AI net revenues growth of approximately
6.4% year-over-year and Digital Operations net revenues growth of approximately7.9% year-over-year on a constant currency basis1 at the midpoint of the range.
- Data-Tech-AI net revenues growth of approximately
- Gross margin of approximately
36.0% . - Adjusted income from operations margin9 of approximately
17.3% . - Adjusted diluted EPS10 in the range of
to$3.52 .$3.59
Genpact's outlook for the first quarter of 2025 is as follows:
- Net revenues in the range of
to$1.20 2 billion , representing year-over-year growth of approximately$1.21 3 billion6.2% to7.2% as reported, or7.1% to8.1% on a constant currency basis.1- Data-Tech-AI net revenues growth of approximately
9.8% year-over-year and Digital Operations net revenues growth of approximately4.1% year-over-year as reported at the midpoint of the range. - Data-Tech-AI net revenues growth of approximately
10.0% year-over-year and Digital Operations net revenues growth of approximately5.4% year-over-year on a constant currency basis1 at the midpoint of the range.
- Data-Tech-AI net revenues growth of approximately
- Gross margin of approximately
35.0% . - Adjusted income from operations margin9 of approximately
16.5% . - Adjusted diluted EPS10 in the range of
to$0.79 .$0.80
Our outlook for the first quarter and full year 2025 reflects foreign currency exchange rates as of January 30, 2025.
1 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period. | ||||
2 Net revenues and Data-Tech-AI net revenues for the full year 2023 include | ||||
3 Both on an as reported and constant currency basis. | ||||
4 Genpact updated the classification of certain revenues from Digital Operations to Data-Tech-AI in the quarter ended March 31, 2024 to more accurately reflect the nature of, and mode of delivery for, the services provided, which have evolved over time. As a result, the revenue from Digital Operations and Data-Tech-AI for the full year 2023 originally reported was | ||||
5 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release. | ||||
6 During the quarter and full year ended December 31, 2023, Genpact completed an intercompany transfer of certain intellectual property rights from non-US to US wholly-owned subsidiaries, which resulted in a non-recurring tax benefit of | ||||
7 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income to adjusted income from operations and GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin are attached to this release. Adjusted income from operations margin for the full year 2023 was derived by adjusting total revenue to exclude | ||||
8 New bookings, an operating measure, represents the total contract value of new contracts and certain renewals, extensions and changes to existing contracts. Regular renewals of contracts with no change in scope are not counted as new bookings. Prior to 2024, new bookings of contracts with longer than five-year terms were limited to the total contract value of the initial five-year term. In 2024, Genpact updated its definition of new bookings to eliminate the five-year limitation. New bookings as reported for the full year 2023 were | ||||
9 Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin is attached to this release. | ||||
10 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release. |
Conference Call to Discuss Financial Results
Genpact's management will host a conference call on February 6, 2025, at 5:00 PM ET to discuss the company's performance for the fourth quarter and full year ended December 31, 2024. Participants are encouraged to register here to receive a dial-in number and unique PIN for seamless access. It is recommended to join 10 minutes before the call starts, although registration and dial-in will be available at any time. A live webcast will be available on the Genpact Investor Relations website. For those unable to attend the live call, an archived replay and transcript will be available on the website shortly after the call.
About Genpact
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.
Safe Harbor
This press release contains certain statements concerning our future growth prospects, including our outlook for 2025, financial results and other forward-looking statements, as defined in the safe harbor provisions of the
Contacts | ||
Investors | Tyra Whelton | |
+1 (908) 418-2995 | ||
Media | Alexia Taxiarchos | |
+1 (617) 259-8172 | ||
GENPACT LIMITED AND ITS SUBSIDIARIES | ||||
Consolidated Balance Sheets | ||||
(Unaudited) | ||||
(In thousands, except per share data and share count) | ||||
As of December 31, 2023 | As of December 31, 2024 | |||
Assets | ||||
Current assets | ||||
Cash and cash equivalents | $ 583,670 | $ 648,246 | ||
Short-term investments | — | 23,359 | ||
Accounts receivable, net of allowance for credit losses of | 1,116,273 | 1,198,606 | ||
Prepaid expenses and other current assets | 191,566 | 209,893 | ||
Total current assets | $ 1,891,509 | $ 2,080,104 | ||
Property, plant and equipment, net | 189,803 | 207,943 | ||
Operating lease right-of-use assets | 186,167 | 182,190 | ||
Deferred tax assets | 298,921 | 269,476 | ||
Intangible assets, net | 53,028 | 26,950 | ||
Goodwill | 1,683,782 | 1,669,769 | ||
Contract cost assets | 202,543 | 200,900 | ||
Other assets, net of allowance for credit losses of | 299,960 | 349,821 | ||
Total assets | $ 4,805,713 | $ 4,987,153 | ||
Liabilities and equity | ||||
Current liabilities | ||||
Short-term borrowings | $ 10,000 | $ — | ||
Current portion of long-term debt | 432,242 | 26,173 | ||
Accounts payable | 27,739 | 36,469 | ||
Income taxes payable | 38,458 | 35,431 | ||
Accrued expenses and other current liabilities | 759,180 | 812,994 | ||
Operating leases liability | 50,313 | 52,672 | ||
Total current liabilities | $ 1,317,932 | $ 963,739 | ||
Long-term debt, less current portion | 824,720 | 1,195,267 | ||
Operating leases liability | 168,015 | 153,587 | ||
Deferred tax liabilities | 11,706 | 15,908 | ||
Other liabilities | 234,948 | 269,041 | ||
Total liabilities | $ 2,557,321 | $ 2,597,542 | ||
Shareholders' equity | ||||
Preferred shares, | — | — | ||
Common shares, | 1,789 | 1,740 | ||
Additional paid-in capital | 1,883,944 | 1,945,261 | ||
Retained earnings | 1,085,209 | 1,236,696 | ||
Accumulated other comprehensive income (loss) | (722,550) | (794,086) | ||
Total equity | $ 2,248,392 | $ 2,389,611 | ||
Total liabilities and equity | $ 4,805,713 | $ 4,987,153 |
GENPACT LIMITED AND ITS SUBSIDIARIES | ||||||
Consolidated Statements of Income | ||||||
(Unaudited) | ||||||
(In thousands, except per share data and share count) | ||||||
Three months ended December 31, | ||||||
2022 | 2023 | 2024 | ||||
Net revenues | $ 1,102,545 | $ 1,146,253 | $ 1,248,741 | |||
Cost of revenue | 717,337 | 738,699 | 802,969 | |||
Gross profit | $ 385,208 | $ 407,554 | $ 445,772 | |||
Operating expenses: | ||||||
Selling, general and administrative expenses | 236,557 | 237,419 | 249,157 | |||
Amortization of acquired intangible assets | 9,862 | 7,454 | 6,496 | |||
Other operating (income) expense, net | 11,038 | (51) | (55) | |||
Income from operations | $ 127,751 | $ 162,732 | $ 190,174 | |||
Foreign exchange gains (losses), net | 6,080 | 576 | (1,487) | |||
Interest income (expense), net | (15,513) | (12,915) | (11,047) | |||
Other income (expense), net | 4,799 | 8,081 | 4,908 | |||
Income before income tax expense | $ 123,117 | $ 158,474 | $ 182,548 | |||
Income tax expense/(benefit) | 33,405 | (132,835) | 40,633 | |||
Net income | $ 89,712 | $ 291,309 | $ 141,915 | |||
Earnings per common share | ||||||
Basic | $ 0.49 | $ 1.61 | $ 0.81 | |||
Diluted | $ 0.48 | $ 1.59 | $ 0.79 | |||
Weighted average number of common shares used in computing | ||||||
Basic | 183,371,581 | 180,956,638 | 175,880,251 | |||
Diluted | 187,525,698 | 183,354,187 | 179,183,557 |
GENPACT LIMITED AND ITS SUBSIDIARIES | ||||||
Consolidated Statements of Income | ||||||
(Unaudited) | ||||||
(In thousands, except per share data and share count) | ||||||
Year ended December 31, | ||||||
2022 | 2023 | 2024 | ||||
Net revenues | $ 4,371,172 | $ 4,476,888 | $ 4,767,139 | |||
Cost of revenue | 2,834,774 | 2,906,223 | 3,077,073 | |||
Gross profit | $ 1,536,398 | $ 1,570,665 | $ 1,690,066 | |||
Operating expenses: | ||||||
Selling, general and administrative expenses | 938,385 | 913,061 | 967,145 | |||
Amortization of acquired intangible assets | 42,667 | 31,463 | 26,476 | |||
Other operating (income) expense, net | 53,195 | (4,716) | (5,616) | |||
Income from operations | $ 502,151 | $ 630,857 | $ 702,061 | |||
Foreign exchange gains (losses), net | 15,392 | 4,274 | 2,937 | |||
Interest income (expense), net | (52,204) | (47,935) | (47,214) | |||
Other income (expense), net | (103) | 15,028 | 19,036 | |||
Income before income tax expense | $ 465,236 | $ 602,224 | $ 676,820 | |||
Income tax expense/(benefit) | 111,832 | (29,031) | 163,150 | |||
Net income | $ 353,404 | $ 631,255 | $ 513,670 | |||
Earnings per common share | ||||||
Basic | $ 1.92 | $ 3.46 | $ 2.88 | |||
Diluted | $ 1.88 | $ 3.41 | $ 2.85 | |||
Weighted average number of common shares used in computing | ||||||
Basic | 184,184,930 | 182,345,548 | 178,385,972 | |||
Diluted | 188,087,240 | 185,141,843 | 180,436,900 |
GENPACT LIMITED AND ITS SUBSIDIARIES | ||||||
Consolidated Statements of Cash Flows | ||||||
(Unaudited) | ||||||
(In thousands) | ||||||
Year ended December 31, | ||||||
2022 | 2023 | 2024 | ||||
Operating activities | ||||||
Net income | $ 353,404 | $ 631,255 | $ 513,670 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | 86,849 | 72,530 | 69,778 | |||
Amortization of debt issuance costs (including loss on extinguishment of debt) | 2,376 | 1,967 | 2,412 | |||
Amortization of acquired intangible assets | 42,667 | 31,463 | 26,476 | |||
Write-down of intangible assets and property, plant and equipment | 1,377 | — | — | |||
Impairment charge on assets classified as held for sale | 32,575 | — | — | |||
Loss on sale of business classified as held for sale | — | 802 | — | |||
Write-down of operating lease right-of-use assets and other assets | 20,307 | — | — | |||
Allowance for credit losses | 1,583 | 3,979 | 13,806 | |||
Unrealized loss/(gain) on revaluation of foreign currency asset/liability | 525 | (1,061) | (11,354) | |||
Stock-based compensation expense | 77,373 | 88,576 | 66,383 | |||
Deferred tax expense (benefit) | (29,151) | (157,932) | 36,610 | |||
Others, net | 863 | 1,477 | (2,179) | |||
Change in operating assets and liabilities: | ||||||
(Increase) in accounts receivable | (112,341) | (130,791) | (96,555) | |||
(Increase) decrease in prepaid expenses, other current assets, contract cost assets, | 3,822 | (39,075) | (73,512) | |||
Increase (decrease) in accounts payable | 14,185 | (8,215) | 8,733 | |||
Increase (decrease) in accrued expenses, other current liabilities, operating lease | (54,329) | 1,862 | 63,340 | |||
Increase (decrease) in income taxes payable | 1,585 | (6,025) | (2,184) | |||
Net cash provided by operating activities | $ 443,670 | $ 490,812 | $ 615,424 | |||
Investing activities | ||||||
Purchase of property, plant and equipment | (50,614) | (55,421) | (82,766) | |||
Payment for internally generated intangible assets (including intangibles under development) | (3,775) | (3,356) | (2,469) | |||
Purchase of short term investments | — | — | — | (23,359) | ||
Proceeds from sale of property, plant and equipment and intangible assets | 60 | 25 | 2,635 | |||
Payment for business acquisitions, net of cash acquired | (33) | (682) | — | |||
Proceeds from / (payment) for divestiture of business | 17,769 | (19,510) | — | |||
Net cash used for investing activities | $ (36,593) | $ (78,944) | $ (105,959) | |||
Financing activities | ||||||
Repayment of finance lease obligations | (12,810) | (12,165) | (11,358) | |||
Payment of debt issuance costs | (3,045) | — | (4,165) | |||
Proceeds from long-term debt | 239,130 | — | 400,000 | |||
Repayment of long-term debt | (620,130) | (19,875) | (433,125) | |||
Proceeds from short-term borrowings | 261,000 | 148,000 | 50,000 | |||
Repayment of short-term borrowings | (110,000) | (289,000) | (60,000) | |||
Proceeds from issuance of common shares under stock-based compensation plans | 27,751 | 39,485 | 17,215 | |||
Payment for net settlement of stock-based awards | (44,942) | (21,529) | (22,278) | |||
Payment of earn-out consideration | (2,437) | (2,399) | — | |||
Dividend paid | (91,837) | (100,014) | (108,466) | |||
Payment for stock repurchased and retired (including expenses related to stock repurchased) | (214,082) | (225,499) | (252,671) | |||
Net cash used for financing activities | $ (571,402) | $ (482,996) | $ (424,848) | |||
Effect of exchange rate changes | (88,368) | 8,033 | (20,041) | |||
Net increase (decrease) in cash and cash equivalents | (164,325) | (71,128) | 84,617 | |||
Cash and cash equivalents at the beginning of the period | 899,458 | 646,765 | 583,670 | |||
Cash and cash equivalents at the end of the period | $ 646,765 | $ 583,670 | $ 648,246 | |||
Supplementary information | ||||||
Cash paid during the period for interest (including interest rate swaps) | $ 51,147 | $ 47,989 | $ 68,913 | |||
Cash paid during the period for income taxes, net of refunds | $ 145,979 | $ 156,733 | $ 113,629 | |||
Property, plant and equipment acquired under finance lease obligations | $ 7,078 | $ 2,459 | $ 11,483 |
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:
- Adjusted income from operations;
- Adjusted income from operations margin;
- Adjusted diluted earnings per share; and
- Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact's GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.
Given Genpact's acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact's management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact's operating results to those of its competitors. For the same reasons, since April 2016, Genpact's management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated. Genpact's management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 "Compensation-Stock Compensation," Genpact's management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact's operating results and those of other companies.
During the second quarter of 2022, Genpact approved a plan to divest a business that was no longer deemed strategic. Given the specialized nature of this business, we anticipated completing a transaction within twelve months after the end of the second quarter of 2022, and therefore, we classified the revenues and expenses related to this business as held for sale with effect from April 1, 2022. During the first quarter of 2023, the Company consummated this transaction and recorded a loss on the sale of the business. During the second quarter of 2023, the Company terminated a lease for office property which was fully impaired as part of a restructuring in the second quarter of 2022 and recorded a gain on such lease termination as restructuring income in the second quarter of 2023. During the fourth quarter of 2023, Genpact completed an intercompany transfer of certain intellectual property rights from non-US to US wholly-owned subsidiaries, which resulted in a non-recurring tax benefit of
Genpact's management provides information about revenues on a constant currency basis so that the revenues may be viewed without the impact of foreign currency exchange rate fluctuations compared to prior fiscal periods, thereby facilitating period-to-period comparisons of the Company's true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period.
Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company's reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.
A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income and net income margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation expense and amortization and impairment of acquired intangible assets. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.
The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months and years ended December 31, 2023 and 2024:
Reconciliation of Net Income/Margin to Adjusted Income from Operations/Margin | ||||||||
(In thousands) | ||||||||
Three months ended | Year ended | |||||||
2023 | 2024 | 2023 | 2024 | |||||
Net income | $ 291,309 | $ 141,915 | $ 631,255 | $ 513,670 | ||||
Foreign exchange (gains) losses, net | (576) | 1,487 | (4,274) | (2,937) | ||||
Interest (income) expense, net | 12,915 | 11,047 | 47,935 | 47,214 | ||||
Income tax expense /(benefit) | (132,835) | 40,633 | (29,031) | 163,150 | ||||
Stock-based compensation expense | 24,726 | 19,107 | 88,576 | 66,383 | ||||
Amortization and impairment of acquired intangible assets | 7,453 | 6,493 | 31,348 | 26,456 | ||||
Restructuring (income) expense | — | — | (4,874) | — | ||||
Operating loss from the business classified as held for sale | — | — | 1,201 | — | ||||
Loss on the sale of business classified as held for sale | — | — | 802 | — | ||||
Adjusted income from operations | $ 202,992 | $ 220,682 | $ 762,938 | $ 813,936 | ||||
Net income margin | 25.4 % | 11.4 % | 14.1 % | 10.8 % | ||||
Adjusted income from operations margin | 17.7 % | 17.7 % | 17.0 % | 17.1 % |
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin | ||||||||
(In thousands) | ||||||||
Three months ended | Year ended | |||||||
2023 | 2024 | 2023 | 2024 | |||||
Income from operations | $ 162,732 | $ 190,174 | $ 630,857 | $ 702,061 | ||||
Stock-based compensation expense | 24,726 | 19,107 | 88,576 | 66,383 | ||||
Amortization and impairment of acquired intangible assets | 7,453 | 6,493 | 31,348 | 26,456 | ||||
Other income (expense), net | 8,081 | 4,908 | 15,028 | 19,036 | ||||
Restructuring (income) expense | — | — | (4,874) | — | ||||
Operating loss from the business classified as held for sale | — | — | 1,201 | — | ||||
Loss on the sale of business classified as held for sale | — | — | 802 | — | ||||
Adjusted income from operations | $ 202,992 | $ 220,682 | $ 762,938 | $ 813,936 | ||||
Income from operations margin | 14.2 % | 15.2 % | 14.1 % | 14.7 % | ||||
Adjusted income from operations margin | 17.7 % | 17.7 % | 17.0 % | 17.1 % |
Reconciliation of Diluted EPS to Adjusted Diluted EPS11 | ||||||||
(Per share data) | ||||||||
Three months ended | Year ended | |||||||
2023 | 2024 | 2023 | 2024 | |||||
Diluted EPS | $ 1.59 | $ 0.79 | $ 3.41 | $ 2.85 | ||||
Stock-based compensation expense | 0.13 | 0.11 | 0.48 | 0.37 | ||||
Amortization and impairment of acquired intangible assets | 0.04 | 0.04 | 0.17 | 0.15 | ||||
Restructuring (income) expense | — | — | (0.03) | — | ||||
Operating loss from the business classified as held for sale | — | — | 0.01 | — | ||||
Loss on the sale of business classified as held for sale | — | — | 0.00 | — | ||||
Tax impact on stock-based compensation expense | (0.01) | (0.02) | (0.10) | (0.05) | ||||
Tax impact on amortization and impairment of acquired intangible assets | (0.01) | (0.01) | (0.04) | (0.04) | ||||
Tax impact on restructuring (income) expense | — | — | 0.01 | — | ||||
Tax impact on operating loss from the business classified as held for sale | — | — | — | — | ||||
Tax benefit on intercompany transfer of intellectual property rights | (0.93) | — | (0.92) | — | ||||
Adjusted diluted EPS | $ 0.82 | $ 0.91 | $ 2.98 | $ 3.28 |
11 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided. |
The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending December 31, 2025:
Reconciliation of Outlook for Net Income Margin to Adjusted Income from Operations Margin12 | ||
Year ending December 31, 2025 | ||
Net income margin | 10.7 % | |
Estimated interest (income) expense, net | 1.0 % | |
Estimated income tax expense | 3.5 % | |
Estimated stock-based compensation expense | 1.6 % | |
Estimated amortization and impairment of acquired intangible assets | 0.5 % | |
Adjusted income from operations margin | 17.3 % |
Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from | ||
Operations Margin12 | ||
Year ending December 31, 2025 | ||
Income from operations margin | 14.9 % | |
Estimated stock-based compensation expense | 1.6 % | |
Estimated amortization and impairment of acquired intangible assets | 0.5 % | |
Estimated other income (expense), net | 0.3 % | |
Adjusted income from operations margin | 17.3 % |
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS12 | ||||
(Per share data) | ||||
Year ending December 31, 2025 | ||||
Lower | Upper | |||
Diluted EPS | $ 3.04 | $ 3.11 | ||
Estimated stock-based compensation expense | 0.46 | 0.46 | ||
Estimated amortization and impairment of acquired intangible assets | 0.15 | 0.15 | ||
Estimated tax impact on stock-based compensation expense | (0.08) | (0.08) | ||
Estimated tax impact on amortization and impairment of acquired intangible assets | (0.04) | (0.04) | ||
Adjusted diluted EPS | $ 3.52 | $ 3.59 |
12 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided. |
The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the quarter ending March 31, 2025:
Reconciliation of Outlook for Net Income Margin to Adjusted Income from Operations Margin13 | ||
Quarter ending March 31, 2025 | ||
Net income margin | 10.1 % | |
Estimated interest (income) expense, net | 1.1 % | |
Estimated income tax expense | 3.3 % | |
Estimated stock-based compensation expense | 1.5 % | |
Estimated amortization and impairment of acquired intangible assets | 0.5 % | |
Adjusted income from operations margin | 16.5 % |
Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from | ||
Operations Margin13 | ||
Quarter ending March 31, 2025 | ||
Income from operations margin | 14.1 % | |
Estimated stock-based compensation expense | 1.5 % | |
Estimated amortization and impairment of acquired intangible assets | 0.5 % | |
Estimated other income (expense), net | 0.3 % | |
Adjusted income from operations margin | 16.5 % |
Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS13 | ||||
(Per share data) | ||||
Quarter ending March 31, 2025 | ||||
Lower | Upper | |||
Diluted EPS | $ 0.68 | $ 0.69 | ||
Estimated stock-based compensation expense | 0.10 | 0.10 | ||
Estimated amortization and impairment of acquired intangible assets | 0.04 | 0.04 | ||
Estimated tax impact on stock-based compensation expense | (0.02) | (0.02) | ||
Estimated tax impact on amortization and impairment of acquired intangible assets | (0.01) | (0.01) | ||
Adjusted diluted EPS | $ 0.79 | $ 0.80 |
13 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-reports-full-year-and-fourth-quarter-2024-results-302370628.html
SOURCE Genpact
FAQ
What were Genpact's (G) full-year 2024 revenue and growth rates?
How much did Genpact (G) increase its dividend and share repurchase authorization in 2024?
What is Genpact's (G) revenue guidance for 2025?
How much did Genpact (G) spend on share repurchases in 2024?